233 related articles for article (PubMed ID: 34943829)
1. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder HM; Maeding N; Wolf M; Cronemberger Andrade A; Vari B; Krisch L; Gomes FG; Blöchl C; Muigg K; Poupardin R; Raninger AM; Heuser T; Obermayer A; Ebner-Peking P; Pleyer L; Greil R; Huber CG; Schallmoser K; Strunk D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943829
[TBL] [Abstract][Full Text] [Related]
2. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
3. A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation.
Wolf M; Poupardin RW; Ebner-Peking P; Andrade AC; Blöchl C; Obermayer A; Gomes FG; Vari B; Maeding N; Eminger E; Binder HM; Raninger AM; Hochmann S; Brachtl G; Spittler A; Heuser T; Ofir R; Huber CG; Aberman Z; Schallmoser K; Volk HD; Strunk D
J Extracell Vesicles; 2022 Apr; 11(4):e12207. PubMed ID: 35398993
[TBL] [Abstract][Full Text] [Related]
4. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Pyzer AR; Stroopinsky D; Rajabi H; Washington A; Tagde A; Coll M; Fung J; Bryant MP; Cole L; Palmer K; Somaiya P; Karp Leaf R; Nahas M; Apel A; Jain S; McMasters M; Mendez L; Levine J; Joyce R; Arnason J; Pandolfi PP; Kufe D; Rosenblatt J; Avigan D
Blood; 2017 Mar; 129(13):1791-1801. PubMed ID: 28126925
[TBL] [Abstract][Full Text] [Related]
5. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.
Monguió-Tortajada M; Roura S; Gálvez-Montón C; Pujal JM; Aran G; Sanjurjo L; Franquesa M; Sarrias MR; Bayes-Genis A; Borràs FE
Theranostics; 2017; 7(2):270-284. PubMed ID: 28042333
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
7. Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes.
Kargar-Sichani Y; Mohammadi MH; Amiri V; Barzegar M; Keshavarz A; Bashash D; Farsani MA
Arch Med Res; 2023 Feb; 54(2):95-104. PubMed ID: 36717322
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles.
Munshi A; Mehic J; Creskey M; Gobin J; Gao J; Rigg E; Muradia G; Luebbert CC; Westwood C; Stalker A; Allan DS; Johnston MJW; Cyr T; Rosu-Myles M; Lavoie JR
Stem Cell Res Ther; 2019 Dec; 10(1):401. PubMed ID: 31852509
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Ghetti M; Vannini I; Bochicchio MT; Azzali I; Ledda L; Marconi G; Melloni M; Fabbri F; Rondoni M; Chicchi R; Angeli D; Ghelli Luserna di Rorà A; Giannini B; Zacheo I; Biguzzi R; Lanza F; Martinelli G; Simonetti G
Biomed Pharmacother; 2023 Sep; 165():115235. PubMed ID: 37536029
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell lines.
Lang JB; Buck MC; Rivière J; Stambouli O; Sachenbacher K; Choudhary P; Dietz H; Giebel B; Bassermann F; Oostendorp RAJ; Götze KS; Hecker JS
Front Oncol; 2022; 12():949261. PubMed ID: 36263223
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics.
Kontopoulou E; Strachan S; Reinhardt K; Kunz F; Walter C; Walkenfort B; Jastrow H; Hasenberg M; Giebel B; von Neuhoff N; Reinhardt D; Thakur BK
Ann Hematol; 2020 Mar; 99(3):459-475. PubMed ID: 31932899
[TBL] [Abstract][Full Text] [Related]
13. Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological malignancies.
Li L; Görgens A; Mussack V; Pepeldjiyska E; Hartz AS; Rank A; Schmohl J; Krämer D; Andaloussi SE; Pfaffl MW; Schmetzer H
Cancer Gene Ther; 2022 Nov; 29(11):1600-1615. PubMed ID: 35477770
[TBL] [Abstract][Full Text] [Related]
14. AML-derived extracellular vesicles negatively regulate stem cell pool size: A step toward bone marrow failure.
Shahrokh B; Allahbakhshian FM; Ahmad G; Fatemeh F; Hossein MM
Curr Res Transl Med; 2023; 71(1):103375. PubMed ID: 36508911
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
[TBL] [Abstract][Full Text] [Related]
16. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
Bouvy C; Wannez A; Laloy J; Chatelain C; Dogné JM
Leuk Res; 2017 Nov; 62():70-76. PubMed ID: 28987820
[TBL] [Abstract][Full Text] [Related]
17. Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response.
Pando A; Fast L; Dubielecka PM; Chorzalska A; Wen S; Reagan J
J Blood Med; 2021; 12():277-285. PubMed ID: 34040472
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
Tohumeken S; Baur R; Böttcher M; Stoll A; Loschinski R; Panagiotidis K; Braun M; Saul D; Völkl S; Baur AS; Bruns H; Mackensen A; Jitschin R; Mougiakakos D
Cancer Res; 2020 Sep; 80(17):3663-3676. PubMed ID: 32605996
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
[TBL] [Abstract][Full Text] [Related]
20. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
Peng M; Ren J; Jing Y; Jiang X; Xiao Q; Huang J; Tao Y; Lei L; Wang X; Yang Z; Yang Z; Zhan Q; Lin C; Jin G; Zhang X; Zhang L
J Extracell Vesicles; 2021 Nov; 10(13):e12168. PubMed ID: 34807526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
